3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
5
Neoplasms
2
Thrombosis
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Glioma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
fludarabine phosphate
18
Cyclophosphamide
16
Peripheral Blood Stem Cell Transplantation
12
Whole-Body Irradiation
11
Busulfan
11
Tacrolimus
10
Mycophenolic Acid
10
ruxolitinib
9
fludarabine
7
Methotrexate
6
Cyclosporine
6
Radiotherapy
5
Aspirin
5
Prednisone
4
Melphalan
4
Imatinib Mesylate
4
Biopsy
4
Antilymphocyte Serum
4
peginterferon alfa-2a
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Specimen Handling
3
Decitabine
3
bomedemstat
2
Thiotepa
2
Surveys and Questionnaires
2
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
2
Methylprednisolone
2
Lenalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Polycythemia Vera
×
apixaban
×
Clear all
NCT04243122
2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2
Completed
44 enrolled